Transplant Associated Thrombotic Microangiopathy (TA-TMA) Is Mechanistically Different in Adults and Children- a MIDAS (Microangiopathy, Endothelial Damage in Adults undergoing Stem cell transplantation) Consortium Study | Synapse
March 3, 2026
Transplant Associated Thrombotic Microangiopathy (TA-TMA) Is Mechanistically Different in Adults and Children- a MIDAS (Microangiopathy, Endothelial Damage in Adults undergoing Stem cell transplantation) Consortium Study
Puntos clave
Thrombotic microangiopathy manifests differently in adults and children, impacting treatment strategies.
Key metrics indicate that the endothelial damage mechanisms differ based on age group, likely influencing patient outcomes.
Assessment using data from the MIDAS Consortium highlights the pathophysiological variations in adults undergoing stem cell transplantation.
This work supports the need for age-specific approaches to prevent vascular complications related to transplant-associated conditions.